Shell Asset Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Shell Asset Management’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,967	Closed	-$49K	–	1503
2020 Q4	$49K	Hold	1,967	–	–	﹤0.01%	1372
2020 Q3	$82K	Hold	1,967	–	–	﹤0.01%	1205
2020 Q2	$94K	Buy	1,967 +11	+0.6%	+$850	﹤0.01%	1163
2020 Q1	$123K	Sell	1,956 -29	-1%	-$2.61K	﹤0.01%	1095
2019 Q4	$246K	Sell	1,985 -14	-0.7%	-$1.25K	0.01%	1096
2019 Q3	$133K	Sell	1,999 -17	-0.8%	-$1.14K	﹤0.01%	1178
2019 Q2	$160K	Sell	2,016 -46	-2%	-$4.12K	﹤0.01%	1142
2019 Q1	$231K	Buy	+2,062	New	+$225K	0.01%	1083

Other funds holding ICPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Shell Asset Management's ICPT Position: Q1 2021 in Review

Shell Asset Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2021, closing a stake of 1,967 shares — an estimated $49K sold.

Shell Asset Management first reported a position in ICPT in Q1 2019 and held it in 8 quarters. The position peaked at $246K in Q4 2019. 151 funds tracked by Wall St. Rank hold ICPT as of Q1 2021.

Shell Asset Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2021 after selling out during the quarter.
Shell Asset Management sold 1,967 Intercept Pharmaceuticals, Inc. shares in Q1 2021, an estimated $49K.
Shell Asset Management first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2019 and held it in 8 quarters.
Shell Asset Management's Intercept Pharmaceuticals, Inc. position peaked at $246K in Q4 2019.
151 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2021.

Based on Shell Asset Management's 13F filing for Q1 2021, filed 10 May 2021.